第 1 章
From Pseudoscience to Modern Medicine: The Remarkable Evolution of Psychiatry
Picture a young woman named Elena, a Yale student who suddenly begins following strangers home and claiming God has placed angels in her parents' bodies. Her wealthy parents had tried everything-life coaches, naturopaths, meditation-before reluctantly consulting a psychiatrist. When diagnosed with schizophrenia and recommended hospitalization, they resisted, illustrating psychiatry's persistent stigma despite its transformation into a scientific, effective medical specialty. After three weeks of medication, Elena's delusions vanished and her natural personality returned-yet her parents remained skeptical and soon discontinued her treatment. This tension between psychiatry's remarkable capabilities and public mistrust forms the central paradox explored in "Shrinks," which Oprah Winfrey called "a game-changing book about mental illness." As the New York Times bestseller that redefined our understanding of mental health treatment, it resonated with celebrities from Leonardo DiCaprio to Michelle Obama, who cited it when launching her mental health initiative.
第 2 章
The Stepchild of Medicine: From Mesmerists to Analysts
Psychiatry's journey began with Franz Anton Mesmer, who claimed to restore proper "magnetic energy flow" by touching patients in strategic ways. Despite his fantastical theories, Mesmer revolutionized mental health by rejecting both determinism (people are born mentally ill) and moral judgment (insanity results from sin), proposing instead that mental illness stemmed from disrupted physiological mechanisms that could be medically treated. Though Benjamin Franklin's committee eventually debunked Mesmer's methods as merely the power of suggestion, his focus on inner psychic processes rather than biology established him as the first psychodynamic psychiatrist.
The field oscillated between competing approaches throughout the nineteenth century. Romantic "Naturalphilosophes" pursued irrational forces through intuition rather than scientific experimentation, culminating in von Feuchtersleben's wildly popular 1845 textbook. When this poetic psychiatry proved ineffective for severe disorders, a reactionary biological psychiatry movement under Wilhelm Griesinger emerged, declaring "all poetical conceptions of insanity are of the smallest value." Despite extensive research examining postmortem brains, nineteenth-century biological psychiatry ultimately failed to find physical evidence of mental illness beyond Alzheimer's disease.
Throughout this period, psychiatrists (then called "alienists") served primarily as compassionate caretakers rather than true doctors. While other medical specialties progressed dramatically with anatomical studies, anesthesia, and X-rays, psychiatry stagnated with ineffective treatments like hypnosis, purges, cold packs, and restraints. As Karl Jaspers noted, mental institutions had become "more magnificent and hygienic than ever," but psychiatrists remained "basically without hope" when it came to actually treating mental illness.
Enter Sigmund Freud, psychiatry's most paradoxical figure-simultaneously its greatest hero and most calamitous influence. Originally trained as a neurologist advocating rigorous scientific standards, Freud's revolutionary concept of the unconscious mind emerged from his work with hypnosis. He dissected the mind into components: the primal id of desires, the virtuous superego of conscience, and the pragmatic ego mediating between them. His psychoanalytic theory proposed that mental illness stemmed from conflicts between these systems, becoming the foundational concept in American psychiatry until 1979.
第 3 章
Down the Garden Path: Psychoanalysis Conquers America
Freud's conception of the mind became so universally embraced that, like smartphones today, it became difficult to remember life before it. Yet unlike rapidly adopted technologies, psychoanalytic theory spread slowly from the idiosyncratic conjectures of an unknown neurologist to become commonplace in our culture.
In autumn 1902, Freud sent postcards to just four local physicians, inviting them to weekly discussions at his modest apartment in Vienna's middle-class Jewish neighborhood. This small gathering-the "Wednesday Psychological Society"-would become the nucleus of an international movement. Meeting Wednesday evenings in Freud's Victorian parlor, the group soon attracted non-physicians including artists and writers. The atmosphere was quasi-religious, with Freud as the new prophet delivering the final word on all discussions.
Freud's "talking cure" established many conventions that persist today: 45-50 minute sessions, comfortable offices with couches, and the concept of transference where the therapist becomes a blank slate for patients to project past relationships. However, rather than embracing the evolution of his ideas through his proteges' contributions, Freud made a fateful decision that would ossify his promising theory into dogma. He began presenting his ideas as articles of faith requiring absolute loyalty, discouraging questioning and thwarting verification efforts.
Anyone criticizing Freud's ideas was considered a blasphemer and excommunicated. Alfred Adler was expelled after disagreeing with Freud's sexual interpretation of all conflicts. Carl Jung, once called Freud's "crown prince and successor," eventually parted ways due to Jung's spiritual leanings that clashed with Freud's atheism. Despite these fractures, by 1910 psychoanalysis had become the treatment of choice among Europe's upper classes.
While Freud's 1909 visit to America initially generated modest interest, psychoanalysis grew slowly until Hitler's rise to power transformed American psychiatry. As Nazism swept Europe, Jewish psychoanalysts fled to America, particularly New York. These emigres-many trained directly by Freud-were welcomed as royalty by American institutions. By 1940, American psychoanalysis had become "a scientifically ungrounded theory, adapted for the specific psychic needs of a minority ethnic group"-poorly suited for treating severe mental illness.
By 1960, psychoanalysts had conquered American psychiatry, occupying nearly every major position in the field. William Menninger became psychiatry's public face, even appearing on Time magazine's cover in 1948 as "psychiatry's U.S. sales manager." From their positions of power, psychoanalysts transformed psychiatric education. Medical students aspiring to become psychiatrists were required to undergo personal psychoanalysis during training-effectively creating an ideological purity test. Those who questioned psychoanalytic dogma were diagnosed with personality disorders or branded sociopaths.
第 4 章
What Is Mental Illness? The Diagnostic Revolution
The Diagnostic and Statistical Manual of Mental Disorders (DSM) has become arguably the most influential book of the past century, affecting how millions live, work, and are treated. It determines billions in healthcare payments, research funding, and legal outcomes from criminal responsibility to disability accommodations. Despite its enormous impact, the DSM evolved from humble beginnings in census-taking.
The first attempt to count mental illness in America came in the 1840 census with a single checkbox for "insane and idiotic"-a crude classification that led to racist applications where some census takers marked entire Black communities as mentally ill. By 1917, the American Medico-Psychological Association created the "Statistical Manual for the Use of Institutions for the Insane" to bring uniformity to institutional record-keeping. However, this manual was limited to asylum statistics and didn't resolve the fundamental problem that psychiatric centers across America used entirely different diagnostic systems.
Emil Kraepelin revolutionized psychiatric diagnosis by organizing mental illnesses not just by symptoms but by their life course. His classification system became the first common diagnostic language for European psychiatrists, supported by vivid clinical portraits drawn from his extensive patient observations. By the 1930s, most European psychiatrists had embraced his classification system, while American psychiatry remained largely under Freudian influence.
Psychoanalytic doctrine viewed mental illness as infinitely variable, emanating from unique unconscious conflicts that couldn't be neatly categorized. This directly opposed Kraepelin's sharp boundary between mental health and illness. The diagnostic approaches diverged dramatically: psychoanalysts looked beyond symptoms to unearth hidden emotional dynamics, while Kraepelinians focused on symptom patterns.
World War II recruitment exposed psychiatry's diagnostic chaos when military officials discovered wildly varying rejection rates for mental health reasons across different draft boards. To address this crisis, the army commissioned William Menninger to develop standardized mental illness diagnoses. The resulting 1943 "Medical 203" classified about sixty disorders and represented the first comprehensive diagnostic system covering both severe institutional cases and milder functional neuroses.
Despite this breakthrough, civilian psychiatrists largely ignored the manual after the war. A 1949 study revealed psychiatrists agreed on diagnoses only 20% of the time when independently evaluating the same patients. This alarming unreliability prompted the American Psychiatric Association to develop a standardized classification system, resulting in the 1952 publication of the first Diagnostic and Statistical Manual of Mental Disorders (DSM-I).
By 1970, the DSM-II was in use-a thin spiral-bound paperback costing $3.50. Published in 1968 with little fanfare, it contained 182 disorders but remained just as vague and inconsistent as its predecessor. This diagnostic anarchy was shattered in 1973 when David Rosenhan published "On Being Sane in Insane Places" in Science. His experiment sent eight normal people to psychiatric hospitals complaining of hearing voices saying "empty," "hollow," and "thud." All were admitted, diagnosed with schizophrenia, and never detected as imposters despite acting normally after admission. The study provoked public outrage and professional embarrassment, leading insurance companies to slash mental health benefits, citing psychiatry's lack of clarity and accountability.
第 5 章
Destroying the Rembrandts: The DSM-III Revolution
Robert Spitzer, an unlikely psychiatric revolutionary, would transform the field. As a teenager, he secretly underwent Reichian therapy and experimented with orgone accumulators before becoming disillusioned and designing experiments that debunked Reich's theories. After medical school, Spitzer trained in psychiatry at Columbia and psychoanalysis at its prestigious Center for Psychoanalytic Training and Research. However, he grew frustrated when his patients rarely improved through psychoanalysis.
Spitzer's involvement with the DSM began when he met Ernest Gruenberg, chair of the DSM-II Task Force, who offered him an unpaid position taking notes and editing. Despite the DSM being considered useless by most psychiatrists, Spitzer's enthusiasm earned him promotion to full Task Force membership at age 34.
His first major contribution came through the homosexuality controversy. After meeting secretly with gay psychiatrists, including department chairs and a former APA president living double lives, Spitzer concluded homosexuality wasn't pathological. In December 1973, the APA officially removed homosexuality from the DSM-II, replacing it with the more limited "sexual orientation disturbance" for those specifically requesting help.
By 1973, psychoanalysts had completely transformed American psychiatry in Freud's image, leaving biological and Kraepelinian psychiatrists isolated. Washington University in St. Louis remained one of the few holdouts against psychoanalytic dominance. Three psychiatrists there-Eli Robins, Samuel Guze, and George Winokur-rejected psychoanalytic theories, noting that nobody had ever proven unconscious conflicts actually caused mental illness. Instead, they advocated returning to Emil Kraepelin's approach of defining disorders by observable symptoms and their course over time.
John Feighner systematically reviewed nearly a thousand published articles on mood disorders to develop evidence-based diagnostic criteria. In 1972, Feighner published these criteria in the Archives of General Psychiatry, explicitly positioning them as "based on data, rather than opinion or tradition"-a direct challenge to psychoanalysis.
When appointed chair of the DSM-III Task Force, Spitzer embraced the Washington University approach and filled half the Task Force with "Feighner types" who shared his vision for more objective diagnosis. Spitzer's revolutionary proposal-removing the concept of etiology (cause) from diagnosis-fundamentally altered psychiatry's understanding of mental illness. Rather than diagnosing based on presumed unconscious conflicts, the DSM-III would identify disorders solely through observable symptoms that caused distress or functional impairment and persisted over time.
As Spitzer's DSM-III faced mounting opposition, the psychoanalysts launched desperate efforts to preserve neurosis-their fundamental concept and primary revenue source-in the manual. Despite multiple compromise proposals, the battle continued to the final vote on May 12, 1979. At the Chicago assembly, after defeating a last-minute attempt to insert "depressive neurosis," the DSM-III received near-unanimous approval with a standing ovation. The DSM-III permanently banished psychoanalytic theory from diagnosis and refocused psychiatry on treating severe mental illnesses with reliable diagnostic criteria.
第 6 章
Desperate Measures: From Barbarism to Modern Treatment
For the first century and a half of psychiatry's existence, institutionalization was the only real treatment for severe mental illness. By 1955, over 550,000 patients languished in asylums like Pilgrim State Hospital, which housed 19,000 patients in its self-contained city. Mary Jane Ward's autobiographical novel "The Snake Pit" exposed the horrors of these institutions: overcrowded rooms, physical restraints, prolonged isolation, and indifferent staff.
In the early twentieth century, Julius Wagner-Jauregg observed that a patient's psychotic symptoms vanished after she experienced fever from a respiratory infection. Theorizing that fever might kill syphilis spirochetes in the brain, he began infecting GPI patients with fever-producing diseases, eventually settling on malaria. Despite a 15% mortality rate, pyrotherapy became the first effective treatment for severe mental illness, earning Wagner-Jauregg the Nobel Prize in 1927.
This success inspired Manfred Sakel to experiment with insulin-induced comas. By overdosing schizophrenic patients with insulin, he induced hypoglycemic comas that seemed to improve psychotic symptoms when patients awoke. The treatment carried severe risks-obesity, permanent brain damage, and death-yet advocates rationalized that brain damage produced a desirable "loss of tension and hostility."
Perhaps the most barbaric treatment was the lobotomy. Moniz and Lima's crude procedure involved drilling holes above each eye and inserting a leucotome to carve out spheres of brain tissue. Walter Freeman adapted the procedure into the American "transorbital lobotomy," using an ice pick hammered through the eye socket bone into the brain. By his death in 1972, Freeman had performed 2,500 such procedures. Remarkably, Moniz received the 1949 Nobel Prize for this procedure that transformed troublesome patients into compliant zombies.
As physicians observed that epileptic patients' psychotic symptoms improved after seizures, they began experimenting with seizure induction. In 1938, Italian neuropsychiatrist Ugo Cerletti developed electroconvulsive therapy (ECT). Unlike lobotomies and other treatments, ECT proved genuinely effective, particularly for depression, with fewer side effects than alternatives. Modern ECT uses minimal electrical current, strategic electrode placement, and muscle relaxants to ensure safety.
第 7 章
Mother's Little Helper: The Pharmacological Revolution
Today's psychiatry is inseparable from medication, but this transformation from talk therapy to pharmacology came through a series of serendipitous discoveries that revolutionized mental health treatment. The first psychotropic drug, meprobamate (Miltown), appeared in 1950, offering something unprecedented: the ability to reduce anxiety without heavy sedation. Despite fierce resistance from traditional psychoanalysts who viewed medication as merely suppressing symptoms, it became psychiatry's first blockbuster drug, with an astounding 36 million prescriptions by 1956. The drug was so culturally significant that it earned the nickname "Mother's Little Helper," later immortalized in the Rolling Stones song of the same name.
In 1949, a breakthrough occurred when French surgeon Henri Laborit made an accidental discovery while preparing patients for surgery. He found that the antihistamine chlorpromazine produced a remarkable state of calm detachment in patients awaiting operations. The drug's potential for psychiatric use became clear when it was administered to Jacques L., a 24-year-old schizophrenic patient whose violent outbursts had made him virtually untreatable. The results were nothing short of miraculous - within days, Jacques became calm and cooperative, resumed normal activities, and was discharged after just three weeks. Unlike traditional sedatives that simply knocked patients out, chlorpromazine actually diminished the psychotic symptoms themselves, offering the first real treatment for schizophrenia. By 1964, over 50 million people worldwide had taken the drug, fundamentally changing the landscape of institutional psychiatry and enabling many patients to return to their communities.
The next major breakthrough came through Roland Kuhn, a Swiss psychiatrist with extensive training in biochemistry. While testing various compounds, he administered "Compound G 22355" to severely depressed patients. The results were stunning - after just six days, a patient named Paula showed dramatic improvement in both mood and sociability. Similar recoveries followed in other patients, leading to the release of imipramine in 1958. As the first tricyclic antidepressant, it revolutionized psychiatry's approach to depression, establishing a biological basis for mood disorders and offering hope to millions of sufferers.
Perhaps the most remarkable discovery came from John Cade, an Australian psychiatrist working in a converted kitchen laboratory. Through careful observation and experimentation, he discovered that lithium had powerful calming effects on agitated patients. When administered to manic patients in 1949, lithium produced extraordinary results, stabilizing their mood swings in ways previously thought impossible. Though regulatory concerns delayed its approval in the United States until 1970, lithium became the world's first effective mood stabilizer for bipolar disorder, completing psychiatry's basic pharmacological arsenal against severe mental illness.
The rise of psychopharmacology in the 1960s represented a direct challenge to psychoanalytic orthodoxy. A new generation of psychiatrists, dubbed psychopharmacologists, embraced medication-based treatments, engaged more directly with patients, and shortened session times - practices considered heretical by traditional analysts. While this transition wasn't without controversy and some instances of overprescription, psychopharmacology had irrevocably transformed psychiatry for the better. It offered genuine hope to those with severe mental illness and demonstrated that mental disorders had biological underpinnings that could be treated with targeted medications, forever changing our understanding of mental health and its treatment.
第 8 章
Out of the Wilderness: The Brain Revolution
The true breakthrough in understanding mental illness came with brain imaging technology. The CAT scan, developed by EMI (ironically funded by Beatles record profits), revealed the first physical brain abnormality in mental illness: enlarged ventricles in schizophrenia patients. This 1976 finding by Eve Johnstone was soon followed by MRI technology in 1981, which provided unprecedented three-dimensional brain imaging.
By the end of the twentieth century, magnificent imaging technologies allowed psychiatrists to examine brain structures with less than a millimeter resolution, trace brain activity to less than a millisecond, and identify chemical compositions-all non-invasively. Research revealed specific brain abnormalities in various mental disorders: schizophrenics showed smaller hippocampi, decreased frontal cortex metabolism during problem-solving, increased glutamate levels, and excessive dopamine release in attention circuits.
Eric Kandel, born in Vienna in 1929, fled Nazi Austria for Brooklyn in 1939. Initially studying European history at Harvard to understand anti-Semitism, his path changed after meeting psychoanalyst Ernst Kris, who suggested studying psychoanalysis to understand human nature. In his senior year of medical school, Kandel made a pivotal decision: to understand Freudian theory by studying the brain itself.
Kandel chose to study memory-the foundation of neurotic conflicts in Freudian theory-but through biological means rather than talk therapy. Through painstaking conditioning experiments on the California sea slug (Aplysia californica), Kandel made the profound discovery that short-term memory involves transient changes in neural connections, while long-term memory requires structural changes through new synaptic growth. His work expanded to anxiety disorders, schizophrenia, addiction, and aging, including identifying the RbAp48 gene's role in memory formation.
As biological psychiatry strengthened, psychodynamic psychiatry was simultaneously advancing. Aaron "Tim" Beck, a Yale-trained psychiatrist and committed psychoanalyst, inadvertently revolutionized talk therapy while attempting to validate psychoanalytic theory. Observing his patients more carefully, Beck noticed depressed individuals experienced streams of distorted "automatic thoughts" reflecting illogical ideas about themselves and the world-not buried anger. This redefined depression as a cognitive rather than anger disorder.
Beck formalized his approach as cognitive-behavioral therapy (CBT), which differed radically from psychoanalysis: it focused on conscious thoughts rather than unconscious impulses, examined immediate emotional experiences rather than historic motives, and remained optimistic about eliminating neurotic tendencies. Unlike psychoanalysis, CBT had defined instructions, specific goals, and finite sessions. It became the first "evidence-based psychotherapy" after controlled experiments validated its effectiveness for depression, anxiety disorders, OCD, and ADHD.
第 9 章
The End of Stigma: Psychiatry's Bright Future
Despite psychiatry's scientific advances, stigma remains its greatest obstacle. Lieberman consulted on Mrs. Kim, a 66-year-old educated, wealthy woman whose family had hidden her schizophrenia in a wing of their home for over thirty years rather than seek treatment. This case exemplifies how stigma remains psychiatry's greatest obstacle-more than any scientific or medical limitations.
Today's psychiatrists are fully integrated with mainstream medicine, approaching mental illness as they would any medical disorder. They combine medication and evidence-based therapies while coordinating with other specialists and allied mental health professionals. Modern psychiatry embraces a pluralistic approach incorporating neuroscience, psychopharmacology, and genetics alongside psychotherapy and psychosocial techniques to provide individualized treatment.
Hollywood has historically reinforced mental illness stigma through films like "Psycho" (1960), which cemented the stereotype of the homicidal maniac. However, recent years have seen a shift toward more nuanced portrayals. Ron Howard's "A Beautiful Mind" depicted economist John Nash's struggle with schizophrenia while achieving professional greatness. The TV series "Homeland" features a brilliant CIA analyst with bipolar disorder supported by her caring psychiatrist sister. "Silver Linings Playbook" presented appealing characters whose mental disorders were just one aspect of their complex lives.
Celebrities increasingly speak openly about mental illness. Jennifer Lawrence highlighted the stigma of brain medication compared to other medical treatments. Glenn Close founded "Bring Change 2 Mind" to combat stigma after her sister was diagnosed with bipolar disorder and her nephew with schizoaffective disorder. Patrick Kennedy, from America's most famous political family, has emerged as a passionate mental health advocate despite early struggles with bipolar disorder and substance abuse.
Psychiatry's future looks bright with unprecedented innovations on the horizon. Genetic research is particularly promising-not in finding single genes for mental illnesses, but in identifying patterns of genes that confer risk, enabling more precise diagnosis and earlier intervention. Diagnostic testing is advancing through multiple technologies: electrophysiology, serology, and brain imaging. Treatment innovations include more precisely targeted drugs and advanced brain stimulation therapies like transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS).
When Elena Conway's parents withdrew her from treatment following her recovery from schizophrenia, her symptoms predictably returned about a year later. After trying more non-medical therapies without success, they eventually placed her in a rural residential facility with a holistic philosophy that also embraced medical approaches. Over six months, her symptoms gradually diminished until she fully recovered. She returned home, resumed her education, and eventually became a sculptor and married an art gallery owner.
Elena's story demonstrates that even someone with severe mental illness can recover and lead a fulfilling life through modern medical treatment. Unlike the past when psychiatrists could barely help patients, today's most significant barriers to life-changing care are stigma and lack of awareness. Though we still have much to learn about mental illness and need better treatments, we now possess the resources, knowledge, and treatments to defeat mental illness. What remains is to change attitudes, eliminate stigma, and make evidence-based mental health care available to all who need it.
